Page last updated: 2024-12-09

15-phenyl-beta-methylpentadecanoic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

15-phenyl-beta-methylpentadecanoic acid is a **synthetic fatty acid** that has a phenyl ring at the 15th carbon and a methyl group at the beta (second) position. This molecule is interesting for research because it's a **potent inhibitor of the enzyme stearoyl-CoA desaturase 1 (SCD1)**.

Here's why SCD1 inhibition is important for research:

* **SCD1 and Metabolism:** SCD1 is a key enzyme in the biosynthesis of monounsaturated fatty acids (MUFAs) like oleic acid. MUFAs play a role in various metabolic processes, including lipid storage, insulin sensitivity, and inflammation.
* **Metabolic Diseases:** Over-activation of SCD1 has been linked to metabolic diseases such as obesity, diabetes, and atherosclerosis. Inhibiting SCD1 can potentially help manage these conditions.
* **Therapeutic Potential:** Because of its inhibitory effect on SCD1, 15-phenyl-beta-methylpentadecanoic acid is being investigated as a potential therapeutic agent for treating metabolic disorders.
* **Understanding SCD1 Function:** This compound is also useful for researchers studying SCD1. By understanding how 15-phenyl-beta-methylpentadecanoic acid interacts with SCD1, scientists can gain insights into the enzyme's structure and function.

**Research Applications:**

* **Drug development:** 15-phenyl-beta-methylpentadecanoic acid is being studied as a potential lead compound for developing new drugs to treat metabolic diseases.
* **Metabolic studies:** Researchers use this compound to understand the role of SCD1 in various metabolic processes.
* **Cell biology:** This molecule can be used to study the effects of SCD1 inhibition on cell function and signaling pathways.

**Note:** While 15-phenyl-beta-methylpentadecanoic acid shows promise as a therapeutic agent, further research is needed to evaluate its safety and efficacy in humans.

Cross-References

ID SourceID
PubMed CID2737146
SCHEMBL ID5074784
MeSH IDM0169735

Synonyms (12)

Synonym
benzenepentadecanoic acid, beta-methyl-
15-phenyl-beta-methylpentadecanoic acid
116754-80-4
3-methyl-15-phenylpentadecanoic acid
15-phenyl-3-methylpentadecanoic acid
SCHEMBL5074784
15-phenyl-3-methyl-pentadecanecarboxylic acid
mfcd00040787
GETJXADZUDOMNR-UHFFFAOYSA-N
DTXSID90922146
FT-0707973
3-methyl-15-phenylpentadecanoicacid
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's3 (50.00)29.6817
2010's2 (33.33)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.34

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.34 (24.57)
Research Supply Index2.08 (2.92)
Research Growth Index4.42 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.34)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]